Home » Headlines » Currently Reading:

Morning Headlines 6/14/19

June 13, 2019 Headlines No Comments

Allscripts is buying ZappRx, a prescription drug start-up

Allscripts will buy specialty drug prescription prior authorization platform vendor ZappRx, according to reports, as it moves toward diversifying its EHR business.

General Electric wants to sell its stake in more than 100 start-ups

GE Ventures looks for a buyer for its stake in 100-plus startups that include 27 healthcare companies, as parent company GE attempts a turnaround.

Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative Platform

French company Dassault Systèmes will acquire clinical trials software vendor Medidata for $5.8 billion.

Sutter secretly sharing patients’ private info with Google, others, Sacramento lawsuit alleges

Two people file a class action lawsuit claiming that Sutter Health is sharing patient medical information with Facebook, Google, and Twitter so those sites can target Internet advertising.



HIStalk Featured Sponsors

     







Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Chuck: With Baylor going Epic, are there any systems left running Allscripts? How much longer can they survive the duopoly?...
  • Jim Beall: Re: COVID 19 news. FWIW the Florida DOH website DOES report daily deaths, although they don't report hospitalization nu...
  • JT: CMS continues to blast out information like nothing else is going on in the world. Can you spell TONE DEAF????...
  • Buckydoc: Any insight into why Castell went with Arcadia rather than Cerner's Healteintent, Intermountain's population health plat...
  • Pay to play: Can we all agree that HCI and Santa Rosa paying a firm to inflate their KLAS numbers is just taking it one step further ...

Sponsor Quick Links